Annual Report

The report describes Biofrontera's strong 2018 growth, with consolidated revenue of EUR 21,107 thousand and 157 Group employees. It highlights the expansion of sales and marketing activities, particularly in the USA, and the increase in production batch size from 7 kg to 35 kg. The report also emphasizes daylight-PDT approval in Europe and the resulting strategic and market-access benefits.